Enalapril maleate (enalapril): Reviews and patient testimonials

Enalapril maleate 10mg Tablets

• Treatment of Hypertension

• Treatment of Symptomatic Heart Failure

• Prevention of Symptomatic Heart Failure in patients with Asymptomatic Left Ventricular Dysfunction (ejection fraction 35%)

(See Section 5.1)

Enalapril can be used alone or in combination with other antihypertensive agents (see sections 4.3, 4.4, 4.5 and 5.1).

Enalapril maleate 20 mg Tablets

• Treatment of Hypertension

• Treatment of Symptomatic Heart Failure

• Prevention of Symptomatic Heart Failure in patients with Asymptomatic Left Ventricular Dysfunction (ejection fraction 35%)

(See Section 5.1)

Enalapril can be used alone or in combination with other antihypertensive agents (see sections 4.3, 4.4, 4.5 and 5.1).

Enalapril maleate 5 mg Tablets

• Treatment of Hypertension

• Treatment of Symptomatic Heart Failure

• Prevention of Symptomatic Heart Failure in patients with Asymptomatic Left Ventricular Dysfunction (ejection fraction ≤35%)

(See Section 5.1)

Enalapril can be used alone or in combination with other antihypertensive agents (see sections 4.3, 4.4, 4.5 and 5.1).

Enalapril Maleate Tablets 10 mg

• Treatment of hypertension

• Treatment of symptomatic heart failure

• Prevention of symptomatic heart failure in patients with asymptomatic left ventricular dysfunction (ejection fraction ≤35%). (See Section 5.1)

Enalapril Maleate Tablets 2.5 mg

• Treatment of hypertension

• Treatment of symptomatic heart failure

• Prevention of symptomatic heart failure in patients with asymptomatic left ventricular dysfunction (ejection fraction ≤35%).

(See section 5.1).

Enalapril Maleate Tablets 20 mg

• Treatment of hypertension

• Treatment of symptomatic heart failure

• Prevention of symptomatic heart failure in patients with asymptomatic left ventricular dysfunction (ejection fraction ≤35%). (See section 5.1)

Enalapril Maleate Tablets 5 mg

• Treatment of hypertension

• Treatment of symptomatic heart failure

• Prevention of symptomatic heart failure in patients with asymptomatic left ventricular dysfunction (ejection fraction ≤35%).